Literature DB >> 25728975

Epithelioid angiomatous nodule of the nasal cavity: Report of 2 cases.

Wai Keat Wong1, David H Lim2, Ching Wern Ong2.   

Abstract

Epithelioid angiomatous nodule (EAN) is a novel clinicopathological entity characterized by a benign proliferation of endothelial cells with prominent epithelioid features. It can arise from any region of the body although it is increasingly being recognized in the head and neck. This paper presents two cases of EAN arising in the nasal cavity where the clinical presentations were recurrent unilateral epistaxis. In both cases, the lesions were excised endoscopically. Histopathologic analysis showed well-circumscribed proliferation of solid sheets of epithelioid endothelial cells and vascular channels in a background of mild chronic inflammatory infiltrate. Cytologic atypia was absent with rare mitotic figures seen. Immunohistochemical studies with CD31 and CD34 were strongly positive, thus confirming a vascular origin. Postoperative recovery was uneventful and no recurrence was seen in the follow-up period. EAN can be differentiated from other lesions demonstrating epithelioid vascular proliferation by means of clinical and histopathological characteristics. The present series seeks to inform that EAN should be regarded as a possible, albeit rare, cause of recurrent unilateral epistaxis. We advocate for endoscopic excision of EAN of the nasal cavity for diagnostic and therapeutic purposes.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Endoscopic sinus surgery; Epistaxis; Epithelioid; Nasal cavity; Vascular tumor

Mesh:

Year:  2015        PMID: 25728975     DOI: 10.1016/j.anl.2015.02.007

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  1 in total

1.  Large cutaneous epithelioid angiomatous nodules in a patient with nephrotic syndrome: A case report.

Authors:  De-Jin Cheng; Xiang-Yue Zheng; Shui-Fu Tang
Journal:  World J Clin Cases       Date:  2020-02-06       Impact factor: 1.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.